XML 41 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Taxes  
Schedule of Gross Deferred Tax Asset and Related Valuation Allowance

 

 

 

 

 

 

 

 

 

    

2017

    

2016

 

Deferred tax assets:

 

 

 

 

 

 

 

Net operating loss carryforward

 

$

30,813,509

 

$

34,451,814

 

Capitalized start-up costs

 

 

1,695,688

 

 

2,708,479

 

Patent amortization

 

 

135,358

 

 

216,203

 

Research and orphan drug credits

 

 

21,293,509

 

 

14,988,522

 

Deferred rent

 

 

71,938

 

 

123,744

 

Deferred compensation

 

 

2,274,885

 

 

2,107,964

 

Other

 

 

69,906

 

 

70,511

 

Total gross deferred tax assets

 

 

56,354,793

 

 

54,667,237

 

Valuation allowance

 

 

(56,354,793)

 

 

(54,667,237)

 

Deferred tax assets

 

 

 —

 

 

 —

 

Deferred tax liabilities:

 

 

 

 

 

 

 

Depreciation

 

 

 —

 

 

 —

 

Total deferred tax liabilities

 

 

 —

 

 

 —

 

 

 

 

 

 

 

 

 

Net deferred tax assets

 

$

 —

 

$

 —

 

 

Schedule of Reconciliations Between Statutory Federal Income Tax Rate and Effective Income Tax Rate of Income Tax Expense

 

 

 

 

 

 

 

 

 

    

2017

    

2016

    

2015

 

U.S. Federal statutory tax rate

 

34.0

%  

34.0

%  

34.0

%

State taxes

 

4.4

 

4.6

 

3.7

 

Research credit

 

1.3

 

1.0

 

5.6

 

Orphan drug credit

 

11.5

 

9.0

 

11.5

 

Other

 

0.3

 

 —

 

 —

 

Stock-based compensation

 

(0.7)

 

(0.7)

 

(1.8)

 

Change in valuation allowance

 

(5.1)

 

(47.9)

 

(53.0)

 

Effective change due to corporate tax rate reduction

 

(45.7)

 

 —

 

 —

 

Provision for income taxes

 

 —

%

 —

%

 —

%